Pharmafile Logo

Pegasus Moves to Brighton

April 29, 2014 |  

Top UK Healthcare Communications Consultancy Moves to Brighton

‘Oh we do like to be beside the seaside!’ Pegasus returns to its roots in Brighton  

As it approaches 20 successful years of business, Worthing based firm Pegasus, the fourth biggest independent health communications consultancy in the UK, is moving the company to its seaside neighbour, Brighton.
 

Keen to stay by the sea, the company is making the short journey along the coast to neighbouring Brighton, positioning itself within the heart of the North Laines on Church Road’s ‘Sovereign House’. The move was prompted by a number of factors; the growing number of staff living in Brighton & Hove and the surrounding area; the strength of its digital and creative offering, and the recruitment pull of being by the sea and at the end of the London commuting line.  

The company’s time in Worthing has seen many successes including significant growth, scores of awards and the launch of new integrated services.  In the last six years alone, staff numbers have grown from 20 to a team of 70. Tripling its income, the consultancy has become a top four UK healthcare comms consultancy and was recently ranked 22nd on The Sunday Times ‘100 Best Places to Work’ (2014).
 

Lisa Bradley, Founder & Managing Director of Pegasus says;
“Whilst Worthing has been a good home for us and helped us get to where we are today, Brighton is actually where the company began all those years ago…in Hove actually.  In many ways it feels like we’re coming home! Brighton offers new opportunities that we are keen to uncover, and being the digital hub of the UK will allow us to strengthen our digital division further. We look forward to supporting the business community and hope to integrate ourselves as well as we have in Worthing.”
 

Pegasus has evolved from a traditional PR agency to become an integrated comms consultancy that offers a multiservice approach to its clients, including; social, digital and creative services.  

With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as; GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil and Danone to name a few.    

As of the 28th of April, Pegasus’s new address will be: Sovereign House, North Laines, Church
Street, BN1 1UJ

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

AI with intent: How Inizio is redefining pharma through precision and partnership

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.